¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"complex precipitated epilepsy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • temporal lobe epilepsy
    °üÀÚ¿±°£Áú, ÃøµÎ¿±°£Áú
  • tardy epilepsy
    ¸¸±â°£Áú
  • antigen-antibody complex
    Ç׿øÇ×üº¹ÇÕü
  • atypical complex hyperplasia
    ºñÁ¤Çüº¹ÇÕÀڱ󻸷Áõ½Ä
  • activated complex
    Ȱ¼ºÈ­º¹ÇÕ, Ȱ¼ºÈ­º¹ÇÕ¹°
  • AIDS-dementia complex
    ¿¡ÀÌÁîÄ¡¸Åº¹ÇÕ
  • basal complex
    ¹Ù´Úº¹ÇÕÃþ
  • circulating immune complex
    ¼øÈ¯¸é¿ªº¹ÇÕü
  • complex
    1. º¹ÇÕ 2. º¹ÇÕü 3. ÄÞÇ÷º½º
  • complex cell
    º¹ÇÕ¼¼Æ÷
  • complex compound
    º¹ÇÕÈ­ÇÕ¹°
  • complex echo pattern
    º¹Çո޾Ƹ®¸ð¾ç, º¹ÇÕ¿¡ÄÚ¾ç»ó
  • complex fracture
    º¹Àâ°ñÀý
  • complex hyperplasia
    º¹ÇÕÁõ½Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • primary epilepsy
    ¿ø¹ß°£Áú, ÀÏÂ÷°£Áú
  • psychomotor epilepsy
    Á¤½Å¿îµ¿°£Áú
  • reflex epilepsy
    ¹Ý»ç°£Áú
  • retrocursive epilepsy
    ÈÄÅð°£Áú
  • running epilepsy
    ÁúÁÖ°£Áú
  • senile epilepsy
    ³ëÀΰ£Áú
  • sensory epilepsy
    °¨°¢°£Áú
  • sleep-related epilepsy
    ¼ö¸é°ü·Ã°£Áú
  • somnambulistic epilepsy
    ¸ùÀ¯º´°£Áú
  • tardy epilepsy
    Áß³âÀÌÈİ£Áú
  • verbomotor epilepsy
    ´Ùº¯¼º°£Áú
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
  • antigen-antibody complex
    Ç׿øÇ×üº¹ÇÕü
  • basal complex
    ¹Ù´Úº¹ÇÕÃþ
  • complex
    º¹ÇÕ, º¹ÇÕü, ÄÞÇ÷º½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Eisenmengers complex
    ¾ÆÀÌÁ¨¸à°Åº¹ÇÕ.
  • Electra complex
    ¿¤·ºÆ®¶óÄÞÇ÷º½º
  • Ghon s complex
    °ïº´º¯±º.
  • Ghon s complex
    °ïº´º¯±º
  • Ghon s primary complex
    °ï¿ø¹ßÁõÈıº.
  • Ghons complex
    °ïº´º¯±º.
  • Golgi s complex
    °ñÁöÀåÄ¡, °ñÁöº¹ÇÕü.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • HLA complex
    HLAÀ¯ÀüÀÚ±Õ.
  • Immune complex
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • Lutembacher s complex
    ·òÅÁ¹Ù½¬¿¡ÁõÈıº.
  • MHC => major histocompatibility complex
    ÁÖÁ¶Á÷ÀûÇÕº¹ÇÕü
  • Oedipism=Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º
  • Oedipus complex
    ¿¡µðǪ½º ÄÞÇ÷º½º.
  • activated complex
    Ȱ¼ºº¹ÇÕ, Ȱ¼ºº¹ÇÕ¹°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gustatory epilepsy
    ¹Ì°¢¼º °£Áú.
  • hereditary epilepsy
    À¯Àü¼º °£Áú(¡­ÊÖòð).
  • hiernosus =epilepsy
    °£Áú(ÊÖòð).
  • hysterical epilepsy
    È÷½ºÅ׸®¼º °£Áú
  • idiopathic epilepsy
    Ư¹ß¼º °£Áú.
  • juvenile myoclonic epilepsy
    û¼Ò³â±Ù°£´ë¼º°£Áú(~ÐÉÊàÓÛàõÊÖòð)
  • laryngeal epilepsy
    Èĵμº Çö±â(¡­úßѨ).
  • latent epilepsy
    Àẹ°£Áú(íÖÜÑÊÖòð).
  • limbic epilepsy personality syndrome
    º¯¿¬°è°£ÁúÀΰÝÁõÈıº(Ü«æÞÍ£ÊÖòðìÑÌ«ñøý¦ÏØ)
  • local epilepsy
    ±¹¼Ò°£Áú(¡­ÊÖòð).
  • major epilepsy
    ´ë°£Áú(ÓÞÊÖòð).
  • masked epilepsy
    °¡¸é°£Áú(Ê£ØüÊÖòð).
  • menstrual epilepsy
    ¿ù°æ¼º °£Áú(¡­ÊÖòð).
  • minor epilepsy
    ¼Ò°£Áú(á³ÊÖòð).
  • morpheic epilepsy
    ¼ö¸éÇü°£Áú(â²Øùû¡ ÊÖòð).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • initiation complex
    °³½Ãº¹ÇÕ¹°(ËÒã·ÜÜùêÚª)
  • junctional complex
    Á¢ÇպΠº¹ÇÕü(ïÈùêÝ»ÜÜùêô÷)
  • low spin complex
    Àú(î¸)½ºÇÉ º¹ÇÕ¹°(ÜÜùêÚª)
  • major histocompatibility complex
    ÁÖ Á¶Á÷ÀûÇÕ º¹ÇÕü(ñ«ðÚòÄîêùêÜÜùêô÷)
  • major immunogene complex
    ÁÖ ¸é¿ªÀ¯ÀüÀÚ º¹ÇÕü(ñ«Øóæµë¶îîí­ÜÜùêô÷)
  • metal bridge complex
    ±Ý¼Ó(ÐÝáÕ) ´Ù¸® º¹ÇÕü(ÜÜùêô÷)
  • Michaelis complex
    ¹ÌŰ¿¤¸®½º º¹ÇÕ¹°(ÜÜùêÚª)
  • mixed complex
    È¥¼ºº¹ÇÕ¹°(ûèà÷ÜÜùêÚª)
  • mononuclear complex
    ´ÜÇÙº¹ÇÕ¹°(Ó¤ú·ÜÜùêÚª)
  • multienzyme complex
    ´ÙÈ¿¼Òº¹ÇÕ¹°(Òýý£áÈÜÜùêÚª)
  • NADH-dehydrogenase complex
    NADH-µðÇÏÀ̵å·ÎÀú³×À̽º º¹ÇÕü(ÜÜùêô÷)
  • nonproductive complex
    ºñ»ý»ê º¹ÇÕü(Þªßæß§ÜÜùêô÷)
  • open-promoter complex
    ¿­¸°ÇÁ·Î¸ðÅÍ º¹ÇÕü(ÜÜùêô÷)
  • polynuclear complex
    ´ÙÇÙ º¹ÇÕ¹°(Òýú·ÜÜùêÚª)
  • productive complex
    »ý»ê º¹ÇÕü(ßæß§ÜÜùêô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
APP acute phase protein; alum-precipitated pyridine; aminopyrazolopyrimidine; amyloid peptide precursor;...
APT alum-precipitated toxoid; aminophenylthioether
diph-tox AP alum precipitated diphtheria toxoid
pptd precipitated
precip precipitate, precipitated, precipitation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
IGE Idiopathic Generalized Epilepsy
ILAE International League Against Epilepsy
JME Juvenile Myoclonic Epilepsy
JAE Juvenile absence epilepsy
MTLE Medial temporal lobe epilepsy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • complex neutrocclusion
    º¹ÇÕ¼±
    ¾È¸ð¿Í º¹ÀâÇÑ ±³Á¤ Ä¡·á¸¦ µ¿¹ÝÇÏ´Â Áß¼º ±³ÇÕ.
  • complex odontoma
    º¹Àâ Ä¡¾ÆÁ¾
  • complex pain
    º¹ÇÕ ÅëÁõ, º¹ÇÕ µ¿Åë
  • complex radical
    ¹æ»ç Âø±â
  • complex simple fracture
    º¹À⼺ ´Ü¼ø °ñÀý
  • complex treatment issue
    º¹ÇÕ Ä¡·á ¹®Á¦
  • condyle-disc complex
    °úµÎ-¿øÆÇ º¹ÇÕü
  • coordination complex
    ¹èÀ§Âø¿°, ¹èÀ§ º¹ÇÕ¹°, ¹èÀ§ °áÇÕ º¹ÇÕü
  • disk-condyle complex
    ¿øÆÇ °úµÎ º¹ÇÕü
  • drug-induced immune complex
    ¾àÁ¦ À¯¹ß¼º ¸é¿ª º¹ÇÕü
  • ego-alien complex
    ÀÚ¾Æ ÀÌÁú ÄÄÇ÷º½º
  • electra complex
    ¿¤·ºÆ®¶ó ÄÞÇ÷º½º
    ÇÁ·ÎÀ̵åÀÇ ¼º°Ý ±¸Á¶·ÐÀÇ ¹ß´Þ ´Ü°è Áß ³²±Ù±âÀÎ 3¼¼¿¡¼­ 6¼¼ »çÀÌÀÇ ¿©ÀÚ ¾ÆÀ̰¡ ¾î¸Ó´Ï¸¦ ¾Æ¹öÁöÀÇ ¼ºÀû °ü½ÉÀÇ °æÀïÀÚ·Î º¸°Ô µÇ°í ¾î¸Ó´Ï¸¦ µÎ·Á¿öÇÏ°Ô µÇ¾î ¾î¸Ó´Ï¸¦ ¹è°ÝÇÏ°í ¾Æ¹öÁö¸¦ »ç¸ðÇÏ´Â Çö»óÀ¸·Î ¾î¸Ó´Ï¿ÍÀÇ µ¿ÀϽð¡ ¿©¾ÆÀÇ ºÒ¾ÈÀ» ÇØ°áÇØ ÁÖ´Â °ÍÀ¸·Î º¸ÀδÙ.
  • immune complex
    ¸é¿ª º¹ÇÕü
    Ç׿ø°ú Ç×üÀÇ Æ¯Á¤ °áÇÕ¹°. ¹ÙÀÌ·¯½º³ª ¼¼±Õ µî À̹°ÀÇ Ä¨ÀÔ¿¡ ´ëÇØ¼­ »ýü°¡ »ý»êÇÑ Ç×ü´Â À̹°ÀÎ Ç׿ø°ú °áÇÕÇÏ¿© ¸é¿ª º¹ÇÕü¸¦ ¸¸µç´Ù. À̴ Ž½Ä ¼¼Æ÷³ª º¸Ã¼¸¦ Ȱ¼ºÈ­ÇÏ¿© À̹°ÀÌ ¹«ÇØÇÑ °ÍÀ¸·Î ºÐÇØÇÏ´Â °ÍÀ» µµ¿Í »ýü ¹æ¾î¿¡ µµ¿òÀ» ÁØ´Ù. Á¶Á÷ Àå¾ÖÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¸é¿ª º¹ÇÕ¼º ÁúȯÀ» ÀÏÀ¸Å°±âµµ ÇÑ´Ù.
  • immune complex-mediated
    ¸é¿ª º¹ÇÕü ¸Å°³¼º
  • intralaminar complex
    Ãþ³» º¹ÇÕü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myoclonus epilepsy A clinically diverse group of epilepsy syndromes, some benign, some progressive. Many are hereditary with mendelian and nonmendelian mitochondrial inheritance. All are characterised by the occurrence of myoclonus, which may be limited or predominate in the condition. Specific syndromes include cherry red spot myoclonus syndrome, ceroid lipofuscinosis, myoclonic epilepsy with ragged red fibres, and Baltic myoclonus.
Synonym: localization related epilepsy.
(05 Mar 2000)
cryptogenic epilepsy tonic-clonic seizure
posttraumatic epilepsy A convulsive state following and causally related to head injury; with brain damage either manifested clinically or ascertained by special examinations such as computed tomography. To assume causal relationship, the individual must have had no previous epilepsy, no cerebral disease, and no other brain trauma. The attacks should have started, depending on the severity of the wounding, within 3 months to 2 years of the alleged trauma and be of a type compatible with the site of injury and the EEG abnormalities.
(05 Mar 2000)
primary generalised epilepsy Epilepsy without evidence of focal or multifocal central nervous system disease. Seizures are generalised from onset, both by EEG and clinical criteria. Often a pure genetic form of epilepsy.
See: generalised tonic-clonic seizure.
(05 Mar 2000)
procursive epilepsy A psychomotor attack initiated by whirling or running.
(05 Mar 2000)
psychomotor epilepsy Attacks with elaborate and multiple sensory, motor, and/or psychic components, the common feature being a clouding or loss of consciousness and amnesia for the event; clinical manifestations may take the form of automatisms; emotional outbursts of temper, anger or show of fear; motor or psychic disturbances; or may be related to any sphere of human activity. Electroencephalographically, the attack is characterised by spike discharges in the temporal lobe, especially in sleep.
See: procursive epilepsy, visceral epilepsy, uncinate epilepsy.
Synonym: automatic epilepsy, psychomotor seizure.
(05 Mar 2000)
secondary generalised epilepsy A group of epilepsy syndromes of diverse aetiologies with diffuse or multifocal cerebral involvement. Patients typically have a variety of generalised seizure types, including tonic, atonic, myoclonic, atypical absence, and generalised tonic-clonic seizures. Partial seizures may also occur. One classic syndrome is the Lennox-Gastaut syndrome.
Synonym: symptomatic epilepsy.
(05 Mar 2000)
sensory epilepsy Focal epilepsy initiated by a somatosensory phenomenon.
(05 Mar 2000)
sleep epilepsy Incorrect term for narcolepsy.
(05 Mar 2000)
somnambulic epilepsy Postictal automatism in which the patient walks or runs about exhibiting natural behaviour of which he or she has no subsequent remembrance.
(05 Mar 2000)
startle epilepsy A form of reflex epilepsy precipitated by sudden noises.
(05 Mar 2000)
nocturnal epilepsy An epilepsy syndrome characterised by nocturnal seizures only.
(05 Mar 2000)
supplementary motor area epilepsy A localization-related epilepsy syndrome in which seizures originate from the supplementary motor area of the mesial frontal lobe. Typical seizure semiology includes sudden bilateral tonic movements, vocalization, and preservation of consciousness. Attacks are often nocturnal.
(05 Mar 2000)
symptomatic epilepsy A group of epilepsy syndromes of diverse aetiologies with diffuse or multifocal cerebral involvement. Patients typically have a variety of generalised seizure types, including tonic, atonic, myoclonic, atypical absence, and generalised tonic-clonic seizures. Partial seizures may also occur. One classic syndrome is the Lennox-Gastaut syndrome.
Synonym: symptomatic epilepsy.
(05 Mar 2000)
diencephalic epilepsy Episodes of autonomic dysfunction presumably due to diencephalic irritation.
Synonym: diencephalic epilepsy, vasomotor epilepsy, vasovagal epilepsy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á